A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ...

A fluorescent micrograph of a section of brain affected by Parkinson's disease. Neuron nuclei are blue, while the protein ...

This has the potential to improve diagnosis and drug development for these diseases. Synucleinopathies are neurodegenerative diseases such as Parkinson’s disease and dementia with Lewy bodies. They ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

REM sleep behavior disorder is characterized by acting out dreams, which may include shouting, kicking and punching during sleep.

A new study supports a link between obstructive sleep apnea and increased risk for Parkinson’s disease and suggests early use ...

ProMIS Neurosciences (PMN) announced that the Company will present preclinical data on computationally-derived vaccines for neurodegenerative ...

Research analysts at Zacks Research boosted their Q1 2025 earnings estimates for Prothena in a research report issued on ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment ...

The presentation will also cover a vaccine developed for synucleinopathies that selectively targets pathogenic alpha-synuclein species, preserving the normal function of the protein. Additionally ...

Across two cohorts, the Automated Imaging Differentiation for Parkinsonism (AIDP) machine learning model distinguished ...